MedTrace Logo

Phantom Limb Pain in Amputees After the 2023 Türkiye Earthquake

NCT06617728 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2024-10-01

No results posted yet for this study

Summary

The goal of this observational study is to investigate the prevalence and persistence of phantom limb pain (PLP) among amputees who experienced limb loss due to injuries sustained during the 2023 Türkiye earthquake. The main questions it aims to answer are:

What is the prevalence of phantom limb pain among earthquake-related amputees at different follow-up intervals? How do different pain management strategies, such as regional analgesia versus intravenous analgesia, affect the severity and persistence of phantom limb pain? Researchers will compare participants receiving regional analgesia to those receiving intravenous analgesia to see if regional techniques are associated with lower rates of phantom limb pain and improved quality of life.

Participants will:

Complete pain assessments using standardized questionnaires at 1 week, 3 months, 6 months, and 12 months post-amputation.

Provide information on their pain management experiences and the impact on their daily activities.

Conditions

  • Phantom Limb Pain
  • Amputation
  • Pain Management
  • Earthquake

Interventions

PROCEDURE

Intervention 1: Regional Analgesia

Regional analgesia techniques like epidural or peripheral nerve blocks.

DRUG

Intervention 2: Intravenous (IV) Analgesia

IV medications used for pain control, including opioids and non-opioid analgesics.

Sponsors & Collaborators

  • Mesut Bakır

    lead OTHER

Principal Investigators

  • Mesut Bakır, Assoc. Prof · Mersin University Faculty of Medicine, Pain Clinic

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-06
Primary Completion
2024-04-30
Completion
2024-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06617728 on ClinicalTrials.gov